Point Therapeutics May File for Chapter 11

Feb 4 (Reuters) - Point Therapeutics Inc said in a regulatory filing that it may file for bankruptcy protection under Chapter 11 if the merger with privately held Dara BioSciences fails and no other strategic deal is completed.

MORE ON THIS TOPIC